Journal articleEur Rev Med Pharmacol Sci2020
Fyn stimulates the progression of pancreatic cancer via Fyn-GluN2b-AKT axis.
- Journal
- Eur Rev Med Pharmacol Sci
- Published
- 1 January 2020
- Citations
- 14
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Objective To assess the expression levels of Fyn in human tissue samples and pancreatic cancer cells and explore the potential mechanisms of Fyn in pancreatic cancer progression. Materials and methods Quantitative PCR and immunohistochemical (IHC) assays were performed to detect the expression of Fyn in 30 cancer tissue samples from pancreatic cancer patients and corresponding adjacent normal tissues. … Excerpt only: this text is the publisher’s. Read it in full at the source.